Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- Check4 days agoChange DetectedRevision update: from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation were observed.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.2 was added to the page footer. Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision history updated: a new entry for v3.4.1 was added and the existing entry for v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded UI controls to show/hide the glossary (Show glossary / Hide glossary). Updated metadata labels and version information, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with capitalization adjustments.SummaryDifference0.3%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.